Re-emergence of bluetongue, African horse sickness, and other orbivirus diseases. by Maclachlan, N James & Guthrie, Alan J
UC Davis
UC Davis Previously Published Works
Title
Re-emergence of bluetongue, African horse sickness, and other 
orbivirus diseases.
Permalink
https://escholarship.org/uc/item/7b63t8vx
Journal
Veterinary research, 41(6)
ISSN
0928-4249
Authors
Maclachlan, N James
Guthrie, Alan J
Publication Date
2010-11-01
DOI
10.1051/vetres/2010007
 
Peer reviewed
eScholarship.org Powered by the California Digital Library
University of California
This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial License
(http://creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted use, distribution, and reproduction in any
noncommercial medium, provided the original work is properly cited.
Review article
Re-emergence of bluetongue, African horse sickness,
and other Orbivirus diseases
N. James MACLACHLAN1*, Alan J. GUTHRIE2
1 Department of Pathology, Microbiology and Immunology, School of Veterinary Medicine,
University of California, Davis, CA 95616, USA
2 Equine Research Centre, Faculty of Veterinary Science, University of Pretoria, Onderstepoort,
0110, Republic of South Africa
(Received 3 November 2009; accepted 25 January 2010)
Abstract – Arthropod-transmitted viruses (Arboviruses) are important causes of disease in humans and
animals, and it is proposed that climate change will increase the distribution and severity of arboviral
diseases. Orbiviruses are the cause of important and apparently emerging arboviral diseases of livestock,
including bluetongue virus (BTV), African horse sickness virus (AHSV), equine encephalosis virus (EEV),
and epizootic hemorrhagic disease virus (EHDV) that are all transmitted by haematophagous Culicoides
insects. Recent changes in the global distribution and nature of BTV infection have been especially
dramatic, with spread of multiple serotypes of the virus throughout extensive portions of Europe and
invasion of the south-eastern USAwith previously exotic virus serotypes. Although climate change has been
incriminated in the emergence of BTV infection of ungulates, the precise role of anthropogenic factors and
the like is less certain. Similarly, although there have been somewhat less dramatic recent alterations in the
distribution of EHDV, AHSV, and EEV, it is not yet clear what the future holds in terms of these diseases,
nor of other potentially important but poorly characterized Orbiviruses such as Peruvian horse sickness
virus.
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1. INTRODUCTION TO THE ORBIVIRUSES
Viruses within the genus Orbivirus, family
Reoviridae, are characterized by icosahedral vi-
rions that include a genome of 10 distinct seg-
ments of linear double-stranded (ds) RNA
[33, 56, 63]. Orbiviruses are transmitted to ani-
mals primarily by arthropod vectors, which,
depending on the individual virus can be certain
species of Culicoides midges, mosquitoes,
black flies, sandflies, or ticks. The global and
seasonal distribution of individual viruses coin-
cides with that of their specific biological vector
and appropriate climatic conditions. Bluetongue
virus (BTV) and African horse sickness virus
(AHSV) are the most economically important
members of this genus, but several others are
potentially important, either regionally or glob-
ally, including Equine encephalosis virus
(EEV), Epizootic hemorrhagic disease virus
(EHDV), Palyam virus, and Peruvian horse
sickness virus (PHSV). With the notable excep-
tion of PHSV that is likely transmitted by mos-
quitoes, all of these viruses are transmitted by
adult females of certain species of haematopha-
gous Culicoides midges. The marked genetic
and phenotypic diversity of BTV, AHSV,
EHDV and EEV is reflected by the multiple
serotypes that occur within each of these virus
species, which can complicate diagnostic and
vaccine strategies for their detection and pro-
phylaxis [20, 48, 54, 84].
The recent emergence of multiple serotypes
of BTV into much of Europe and portions of
North America, the emergence of EEV and
EHDV and novel strains of BTV in Israel, and
the appearance of multiple serotypes of AHSV
in sub-Saharan Africa, has fuelled concerns
regarding the likely impact of climate change
on the potential emergence of these diseases
[5, 29, 30, 89]. This concern is consistent with
the premise that climate change will favour
emergence of arthropod-transmitted diseases
because it will promote expansion of the range
of tropical insects and the agents they transmit
[34, 35, 53, 68, 74, 85]. However, the emer-
gence or re-emergence of arthropod-transmitted
diseases in general, and those caused by Orbiv-
iruses in particular, is likely to be a highly com-
plex process driven by a wide variety of
potential factors [11, 58, 65, 66, 75, 91]. Indeed,
the recent spread of several arboviral diseases
appears to have resulted not so much from the
direct effects of climate change itself but from
anthropogenic and social factors, and/or the
movement (translocation) of virus-infected vec-
tors or their hosts. The true role climate change
in causing the recent global expansion of the
range and distribution of BTV and other Orbi-
viruses, therefore, remains conjectural.
2. BLUETONGUE
2.1. History and background
Bluetongue (BT) is a non-contagious, insect-
transmitted disease of ruminants, particularly
sheep and certain species of non-African wild
ruminants [57, 84]. The disease was first
described in the Cape Colony of southern Africa
after merino sheep were introduced into the
region in the late 18th century, and was subse-
quently recognized in other parts of Africa,
Europe, the Middle East and Indian subconti-
nent, the Americas, and Asia. Twenty-four
(likely 25) serotypes of BTV are recognized
globally [43], and the virus has now been iso-
lated on all continents except Antarctica. The
traditional global range of BTV has been con-
sidered to reside between latitudes of approxi-
mately 40–50 N and 35 S; thus the northern
limits previously were considered to be south-
ern British Columbia in North America and
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Kazakhstan and Mongolia in Asia, and the
southern limits in Africa, Australia and South
America were, respectively, southern South
Africa, northern New SouthWales, and northern
Argentina. The species ofCulicoides insects that
serve as the principal vectors of the virus differ
between regions, as do the constellations of
BTV serotypes and genetic strains (topotypes)
that occur within each [55, 79].
BT is characterized by BTV-induced vascu-
lar injury that results in haemorrhage and ulcer-
ation of the mucous membranes in the upper
portion of the gastrointestinal tract; coronitis
and laminitis; facial and intermuscular oedema;
pleural and pericardial effusion; pulmonary
oedema; and necrosis of skeletal and cardiac
muscle [57, 77, 84]. BT was infrequently
described in cattle prior to emergence of BTV
serotype 8 in Europe, however sheep, cattle,
goats, camelids (llamas, alpacas), bison, yaks,
deer and even zoo carnivores such as Eurasian
lynx have all been affected during this ongoing
pandemic [21, 27, 50, 57, 59]. In addition to
causing clinical disease in domestic and wild
ungulates, BTV serotype 8 infections has
caused reproductive failure amongst pregnant
cattle and sheep and a high rate of vertical virus
transmission with teratogenic defects in con-
genitally infected calves [24, 87, 88].
BTV infection of ruminants results in pro-
longed, but not persistent cell associated vira-
emia [57]. Highly sensitive and specific
serological (competitive ELISA) and virus
detection (quantitative PCR) assays are now
widely available to confirm the presence or
absence of BTV infection in animals [42]. Fur-
thermore, infection with one BTV serotype con-
fers long-term (likely life-long) immunity to the
homologous serotype. Thus, livestock can
safely be moved into BTV-free regions regard-
less of the status of the exporting region, but
only with stringent adherence to appropriate
testing and quarantine practices as prescribed
by the World Organisation for Animal Health
(OIE) [6].
2.2. Evolution of BTV
There is extensive genetic heterogeneity of
field strains of BTV, and this genetic variation
is likely responsible for differences in the viru-
lence and other biological properties of individ-
ual field strains of the virus. This diversity
arises as a consequence of both genetic shift
and genetic drift, the latter as a result of reas-
sortment of viral genes during mixed infections
of either the vertebrate or invertebrate hosts fol-
lowing infection with more than one virus sero-
type or strain [17]. Variation in the nucleotide
sequence of each of the 10 dsRNA segments
of the BTV genome occurs as a result of the
complex process of quasispecies evolution and
founder effect during alternating passage of
BTV in its ruminant and insect hosts [16]. Fur-
thermore, negative (purifying) selection of indi-
vidual BTV genes occurs over time following
the incursion of novel viruses into new regions,
creating genetically distinct region-specific
clusters (topotypes) of certain virus genes
[9, 15]. Genetic differences are responsible for
clearly documented differences in phenotypic
properties (such as virulence) of BTV strains,
even of the same serotype, and can complicate
the design and use of nucleic acid based virus
detection methods such as reverse transcriptase
polymerase chain reaction (RT-PCR) assays.
The genetic determinants of BTV virulence
remain uncharacterized, however, as do those
that presumably are responsible for, or associ-
ated with, emergence of the virus in new
regions and in novel vector species.
2.3. Global emergence of BTV
The global distribution and nature of BTV
infection has changed significantly in recent
years, and climate change has been implicated
as a potential cause of this dramatic event, espe-
cially in Europe [29, 69, 70].
2.3.1. Europe
Until recently, only transient incursions of
single serotypes of BTV had occurred in Europe
but, since 1998, at least 8 different serotypes of
BTV have emerged and persisted in Europe
causing substantial economic losses through
mortality and reduced productivity of affected
animals, the requirement for mass vaccination
of susceptible livestock, and restrictions on the
Re-emerging Orbivirus diseases Vet. Res. (2010) 41:35
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movement and trade of animals from affected
regions [86]. A current distribution map of
restriction zones for individual BTV serotypes
within Europe is available at http://ec.euro-
pa.eu/food/animal/diseases/controlmeasures/
bt_restrictedzones-map.jpg. Five BTV serotypes
(1, 2, 4, 9 and 16) initially invaded the Mediter-
ranean basin by extension from adjacent regions
of either North Africa or the Middle East1.
Although these 5 serotypes have persisted in
extensive portions of the Mediterranean basin,
onlyBTVserotype 1 has since spread to northern
Europe. Subsequent to the spread of BTV sero-
types 1, 2, 4, 9 and 16 within the Mediterranean
basin, BTV serotypes 6, 8 and 11 all appeared in
northern Europe (Benelux) after 2006; whereas
the strains of BTV serotypes 6 and 11 are closely
related to South African live attenuated vaccine
viruses1 [25], the origin of the highly pathogenic
strain of BTV serotype 8 that has now spread
throughout much of Europe remains unknown.
Since its appearance in northern Europe, this
virus has now spread to theMediterranean basin,
Scandinavia, and the Middle East. This strain of
BTV serotype 8 exhibits several distinctive fea-
tures that are unusual amongst other field strains
of BTV, notably its ability to cross the ruminant
placenta with high frequency [88]. Vertical trans-
mission has previously been considered to be lar-
gely or exclusively a property of BTV strains
modified by growth in embryonated eggs or cell
culture [57].
An additional remarkable feature of the BT
pandemic in Europe is the recognition of sev-
eral apparently new vector species, including
Palaearctic species such as Culicoides chiopte-
rus, C. dewulffi, C. obsoletus, C. scotius, and
C. pulicaris [86]. These insects were all resident
in Europe long before the emergence of multi-
ple serotypes of BTV, suggesting that environ-
mental changes may have been responsible
for their recent ability to serve as efficient vec-
tors of the virus [69, 70]. While it is proposed
that recent environmental changes have facili-
tated expansion of the range of known vectors
such as Culicoides imicola, the traditional
Asian/African vector, this opinion is strongly
disputed by others. Importantly, several of the
Palaearctic Culicoides species that are now effi-
ciently transmitting BTV in the absence of
known vectors such as C. imicola, also occur
throughout the Holarctic region that includes
North America [18]. This raises the unnerving
possibility that the viruses that have recently
spread throughout extensive portions of Europe,
especially the unusual and highly virulent strain
of BTV serotype 8, might even further expand
their global range in the future.
2.3.2. North America, Australia and the
Middle East
Five BTV serotypes have long been recog-
nized as enzootic in North America, specifically
serotypes 10, 11, 13 and 17 occur throughout
much of the continent coincident with the distri-
bution of C. sonorensis, whereas serotype 2 is
restricted to the south-eastern USA apparently
because of its reliance on C. insignis for trans-
mission [55, 79]. Since 1998 ten additional pre-
viously exotic serotypes (1, 3, 5, 6, 9, 12, 14,
19, 22, 24) have also been isolated in the
south-eastern USA, but without any obvious
associated disease outbreak2. The majority
(but not all) of these virus serotypes were previ-
ously identified in the Caribbean/Central
America ecosystem, as determined by either
virus isolation or serological studies on rumi-
nants in the region [79]. Thus, the BTV sero-
types that recently have encroached into the
south-eastern USA have likely originated in
the adjacent tropical ecosystem to the immedi-
ate south, where C. insignis and possibly other
species such as C. pusillus, C. furens, C. filari-
fer and C. trilineatus are the vectors of numer-
ous BTV serotypes [58]. The importance of
vector species other than C. sonorensis is lar-
gely undetermined in North America, and there
has been little or no comprehensive, prospective
surveillance of the viruses and vectors present1 Mertens P.P.C., Maan S., Potgieter A.C.,
Nomikou K., Maan N.S., The molecular epidemi-
ology of bluetongue virus infection in Europe:
impact of vaccination, Proc. Ann. Mtg. US Anim.
Health Assoc. (2009) (in press).
2 Ostlund E.N., NVSL update to the bluetongue
and related Orbiviruses Committee, Proc. Ann.
Mtg. US Anim. Health Assoc. (2009) (in press).
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in the USA and Caribbean basin/Central Amer-
ica for several decades.
Additional novel serotypes of BTV have also
recently invaded Israel and Australia, countries
that previously had stable annual cycles of
BTVinfection (virus serotypes and distribution),
as shown by ongoing surveillance over many
years. Specifically, BTV serotypes 2, 4, 6, 10,
16 previously were recognized in Israel, but ser-
otypes 5, 8, 15 and 24 have all recently emerged
in the country and the occurrence of serotype
24 in particular was associated with very high
mortality in infected sheep. Interestingly, BTV
serotype 24 also recently appeared in the south-
eastern USAwithout any associated disease out-
break, further confirming that serotype alone
does not determine the virulence of individual
field strains of BTV [57]. Similarly, 8 serotypes
(1, 3, 9, 15, 16, 20, 21, 23) of BTV previously
have been identified in Australia, of which only
two (serotypes 1 and 21) annually spread into
eastern Australia as far south as northern New
South Wales; however, BTV serotypes 2 and 7
were recently identified for the first time in the
Northern Territory of Australia. Finally, BTV
infection is enzootic in the Indian subcontinent
with the presence of at least 21 serotypes of the
virus, however there are multiple recent, largely
unexplained, reports of the emergence of virulent
BT disease amongst indigenous breeds of sheep.
2.4. Summary
The essential question remains as to why
BTV has recently emerged in previously unaf-
fected regions, and why exotic virus serotypes
have spread into regions with previously stable
enzootic infection with specific virus serotypes.
In the south-eastern USA, northern Australia,
and southern Europe, it is very likely that most
if not all of these novel, emergent BTV sero-
types have originated and spread from adjacent
tropical or subtropical ecosystems. It is to be
stressed that subsequent virus transmission
within these newly affected regions clearly
requires the presence of competent resident
Culicoides vectors, which in several recent
instances involves virus transmission by indige-
nous insect species that previously were not
considered to be competent vectors of BTV.
Climate events such as storms, typhoons and
hurricanes have been frequently proposed to
be responsible for the wind-borne dissemination
of virus-infected Culicoides midges, but long-
distance dissemination of virus-infected insects
likely can occur simply on prevailing winds.
For instance, there is compelling evidence that
BTV serotype 8 was spread in 2007 from con-
tinental Europe to adjacent regions of England
by wind-borne insects, after which there was
limited regional dissemination by resident
insects [32]. Wind-borne insects are believed
to have also been responsible for the recent
spread of BTV from North Africa to southern
Europe, and between Mediterranean islands,
in some instances involving distances of up to
several hundred kilometres. It has even been
proposed that serotypes of BTV that occur in
Africa can be spread to the Americas by
virus-infected insects carried on the trade winds
[31], a finding that is consistent with genetic to-
potyping studies of global BTV strains. Specif-
ically, genetic analysis of conserved genes of
BTV strains from the around the world segre-
gates these viruses into so-called ‘‘eastern’’
(Asia, Southeast Asia, Australia, Indian subcon-
tinent) and ‘‘western’’ (Africa, the Americas)
lineages, consistent with common ancestry of
the viruses in each lineage1 [9, 15].
In contrast, both the route of introduction
and origin of the strain of BTV serotype 8 that
recently invaded northern Europe are uncertain,
and this event very clearly represents a long-
distance translocation of BTV into a region
devoid of C. imicola, the principal African/
Asian vector of BTV. The strain of BTV sero-
type 8 is unrelated to the South African live
attenuated vaccine virus of that serotype
whereas the strains of BTV serotypes 6 and
11 that recently appeared in northern Europe
are apparently derived at least in part from
South African live attenuated vaccine viruses1
[25], although their precise route and mecha-
nism of introduction also remains a mystery.
The very disconcerting message from these
recent events to the rest of the world, therefore,
is that exotic strains of BTV can be translocated
into previously free regions, including those
devoid of known vector species but in which
other putatively ‘‘non vector’’ Culicoides
Re-emerging Orbivirus diseases Vet. Res. (2010) 41:35
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species are resident. Furthermore, the remark-
able expansion of BTV serotype 8 into northern
Europe and Scandinavia indicates that climate
no longer can be relied on to confine BTV to
its traditional global range between 40–50 N
and 35 S. It is difficult to predict therefore,
what the global range and distribution of BTV
will become in coming years.
3. AFRICAN HORSE SICKNESS
3.1. History and background
African horse sickness (AHS) is a non-conta-
gious, insect-transmitted disease of equids
caused byAHSV. In horses, the disease is usually
peracute to acute and in naive animals more than
90% of those affected die.Mules are less suscep-
tible than horses andAfrican donkeys and zebras
rarely showclinical signs of disease [36, 37]. The
first known historical reference to a disease
resembling AHS was reported in Yemen in
1327 [41]. Documents reporting on the travels
of Portuguese explorers in East Africa in 1569
report AHS affecting horses imported from India
[41]. Neither horses nor donkeys were indige-
nous to southern Africa but were introduced
shortly after the arrival of the first settlers of the
Dutch East India Company in the Cape of Good
Hope in 1652 [83]. Dutch East India Company
recordsmake frequent reference to ‘‘perreziekte’’
or ‘‘pardeziekte’’ in the Cape of GoodHope [83]
including an outbreak in 1719 during which
about 1 700 horses died of AHS. AHS has sub-
sequently been recognized in other parts of sub-
Saharan Africa where AHSV is considered to be
enzootic.
Nine serotypes of AHSV are recognized
[45, 61]. Like BTV, AHSV is biologically trans-
mitted by Culicoides spp., of which C. imicola
and C. bolitinos have been shown to play an
important role in Africa [62]. The disease has
a seasonal occurrence and its prevalence is influ-
enced by climatic and other conditions that
favour the breeding ofCulicoides spp. Although
other insects have been suggested as possible
vectors of AHSV, none have been shown to play
a role under natural conditions. AHSV can be
transmitted between horses by parenteral inocu-
lation of infective blood or organ suspensions
and it is more readily transmitted by the intrave-
nous than by the subcutaneous route [82].
AHS is characterized by pyrexia, inappe-
tence and clinical signs and lesions compatible
with impaired respiratory and vascular functions
with oedema of subcutaneous and intermuscular
tissues and of the lungs, transudation into the
body cavities, and haemorrhages, particularly
of the serosal surfaces. Dogs are the only other
species that contract a highly fatal form of
AHS [39, 80]. All reported clinical cases in dogs
have resulted from the ingestion of infected car-
cass material from horses that have died from
AHS [12, 67]. However, it is doubtful that dogs
play any role in the epidemiology of AHS, as
Culicoides spp. do not readily feed on them
[60]. Neither domestic ruminants nor wildlife,
besides zebra [10, 13, 22, 28], have been shown
to play a significant role in the epidemiology of
AHS. In contrast to some strains of BTV, espe-
cially the European strain of BTV serotype 8,
AHSV infection does not cause reproductive
failure amongst pregnant equids.
AHSV infection of equids results in a cell
associated, predominantly erythrocyte associ-
ated viraemia of up to 28 days in horses and
up to 40 days in zebra. Highly sensitive and
specific virus detection (quantitative PCR)
assays are now more widely available to con-
firm the presence or absence of AHSV infection
in equids. Thus, horses can safely be moved
into AHSV-free regions regardless of the status
of the exporting region, but only with stringent
adherence to appropriate testing and quarantine
practices as prescribed by OIE [7].
3.2. Evolution of AHSV
Like BTV, there is extensive genetic hetero-
geneity of field strains of AHSV that potentially
determines the biological behaviour and proper-
ties of individual virus strains, including their
virulence [19]. This genetic diversity also likely
arises as a consequence of both genetic shift
and genetic drift, the latter as a result of reas-
sortment of viral genes and the former through
quasispecies evolution of the virus in its verte-
brate host followed by founder effect in feeding
insects that results in variation in the nucleotide
Vet. Res. (2010) 41:35 N.J. MacLachlan, A.J. Guthrie
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sequence of each of the 10 dsRNA segments of
the AHSV genome. Like those of field strains
of BTV, individual AHSV gene segments fur-
ther evolve over time through negative (purify-
ing) selection [71]. The genetic determinants of
AHSV virulence remain uncharacterized, as do
those that might determine whether or not the
virus can emerge in novel vector species.
3.3. Emergence of AHSV
Nine antigenically distinct serotypes of
AHSV have been described [45, 61]. While
there may be some cross relatedness between
the serotypes there is no definitive evidence of
any intratypic variation [45, 61]. All 9 serotypes
have been documented in eastern [23] and
southern Africa [14, 45, 61] while serotype 9
is more widespread and appears to predominate
in the northern parts of sub-Saharan Africa
[1, 76]. AHS has been periodically recorded
beyond its traditional enzootic range in sub-
Saharan Africa, including in Egypt in 1928,
1943, 1953, 1958 and 1971 [37], in Yemen in
1930 and in Palestine, Syria, Lebanon and
Jordan in 1944 [2]. In 1959, AHS serotype 9
occurred in the south-eastern portion of Iran.
This was followed by outbreaks during 1960
in Cyprus, Iraq, Syria, Lebanon and Jordan as
well as in Afghanistan, Pakistan, India and
Turkey. Between 1959 and 1961, more than
300 000 equids were lost to AHS [44, 46, 72].
In 1965 AHS occurred in Libya, Tunisia,
Algeria and Morocco and subsequently spread
to Spain in 1966 [40]. Between 1987 and
1990, AHS serotype 4 occurred in Spain with
the virus being introduced by zebra (Equus
burchelli) imported from Namibia [52, 73].
AHS was also confirmed in southern Portugal
in 1989 and Morocco between 1989 and 1991
with these outbreaks being extensions of the
outbreak in Spain [92]. In 1989, an outbreak
of AHS serotype 9 occurred in Saudi Arabia
[4]. AHS was also reported in Saudi Arabia
and Yemen in 1997 and on the Cape Verde
Islands in 1999. Serotypes 6 and 9 of AHSV
were isolated from samples collected from eq-
uids in Ethiopia in 2003 [90] and serotype 2
has resulted in the death of approximately
2 000 horses in Ethiopia in 2008. Serotypes 2
and 7 of AHSV were isolated in Senegal in
2007 and serotype 2 was isolated in Nigeria in
2007. AHS was also reported in The Gambia
in 2007. AHSV can be distributed over great
distances if equids incubating the disease are
translocated by land, sea or air [52, 73]. Spread
of AHS can also occur as a result of wind-borne
spread of infected vectors [78].
3.4. Summary
There have been numerous documented
prior extensions of AHSV from its enzootic
domain within sub-Saharan Africa into North
Africa, Europe and the Middle and Near East.
The only recorded introduction of AHS from
an enzootic to a free region that occurred as
the result of legal trade in equids was the out-
break on the Iberian Peninsula in the 1980s,
which was associated with import of zebra from
Namibia without application of appropriate san-
itary conditions. The European Union has now
harmonized import conditions and other veteri-
nary administrations are acutely aware of risks
associated with import of exotic species and
therefore a reoccurrence is unlikely.
All 9 serotypes of AHSVoccur in eastern and
southern Africa, however there recently has
been an increase in the number of serotypes
present within the northern limits of the virus’
range in sub-Saharan Africa. This spread of at
least 3 different serotypes into these areas is dis-
concerting because recent experiences with
BTV indicate that once these viruses reach
North Africa they readily can spread throughout
the Mediterranean basin. The incursion of
AHSV into countries of Europe or the Middle
East that are extensively involved in the interna-
tional trade and movement of horses would be
economically devastating, thus there is substan-
tial current concern regarding potential spread of
AHS from Africa into adjacent regions [26, 29].
4. OTHER ORBIVIRUS DISEASES
4.1. Equine encephalosis
Equine encephalosis (EE) is usually a mild
or subclinical Orbivirus infection of horses
Re-emerging Orbivirus diseases Vet. Res. (2010) 41:35
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[38]. The virus is transmitted by species of
Culicoides that are endemic to the temperate
regions of Africa and, as a result, the epidemi-
ology of EEV infection has much in common
with AHS. The disease referred to as ‘‘equine
ephemeral fever’’ by Sir Arnold Theiler in the
early 1900s [81] is probably the first description
of EE. Fatal EEV infection can occur, but rarely
[47, 49]. EEV has long been enzootic in of
Africa but was described recently for the first
time in Israel [64]. The Israeli outbreak was
widespread and infected horses exhibited pyr-
exia, oedema of the neck, legs, eyelids and lips,
but without mortality. Similar clinical signs
were also associated with a recent outbreak of
EE in Thoroughbred weanlings in the Western
Cape Province of South Africa3.
4.2. Epizootic hemorrhagic disease
EHDVis an Orbivirus closely related to BTV
that occurs throughout much of the world,
including the Americas, Africa, Australia and
Asia [54]. Ibaraki virus (EHDV serotype 2), is
the cause of Ibaraki disease of cattle in Japan
[51]. Two EHDV serotypes (serotypes 1 and 2)
have long been enzootic in North America,
where they cause fatal hemorrhagic disease in
wild ruminants, especially white-tailed deer.
A third EHDV serotype (serotype 6) recently
emerged in theUSA, and this virus has nowbeen
isolated as far north as the state of Michigan [3].
Interestingly, EHDV serotype 6, whichwas orig-
inally isolated in Australia, also has emerged
amongst cattle in North Africa and Turkey.
Affected cattle in North Africa exhibited BT-like
disease, as did cattle in Israel infected with
EHDV serotype 7 [89].
4.3. Peruvian horse sickness
PHSV is a mosquito-transmitted Orbivirus
that is the cause of outbreaks of encephalitis
amongst horses in South America [8]. A very
similar, likely identical virus, Elsey virus, is
present in the Northern Territory of Australia
where infection can cause encephalitis like that
described with PHSV. The epidemiology of the
infections caused by these viruses is poorly
characterized, and it is uncertain how identical
viruses came to be present in such distinct
regions of the world.
5. FUTURE PERSPECTIVES
It is abundantly clear that the global distribu-
tion of several Culicoides-transmitted Orbivirus
infections of livestock has altered drastically of
late, although the precise mechanism(s) respon-
sible for these events is less certain. Specifically,
it is clear that thewind-borne dispersion of virus-
infected Culicoides insects as ‘‘aerial plankton’’
can translocate these viruses over long distances,
as can the movement of virus-infected livestock.
Human interventions, including the intentional
or unintentional introduction of products that
contain Orbiviruses, also can result in long-
distance translocation of these viruses as previ-
ously shown with the introduction of AHS into
Spain through the importation of infected zebra
and the translocation of BTV serotype 1 from
south-eastern France to Brittany by illegalmove-
ment of livestock. Viruses that are transmitted
vertically, notably the strain of BTV serotype 8
that recently has spread rapidly after its original
incursion into northern Europe, can be expected
to contaminate foetal tissues and fluids such as
foetal bovine serum and so all such products
from animals in enzootic regions are a potential
source of virus.
Once Orbiviruses are translocated into new
regions, subsequent virus dissemination requires
that resident Culicoides are able to acquire and
transmit the specific virus. The environmental
(including climatic), virus and vector (insect)
determinants that determine vectorial capacity
are only now being defined, thus many current
risk analyses are based on data that are of dubi-
ous relevance and validity. The reality is that
several Orbiviruses recently have expanded
their global range, and it is difficult to accurately
predict which of the many species of Culicoides
insects that occur worldwide ultimately will be
proven to be vectors of these viruses. Until
3 Grewar J.D., Use of temperature sensitive micro-
chip transponders to monitor body temperature and
pyrexia in Thoroughbred foals, MSc Dissertation,
University of Pretoria, South Africa, 2009.
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better predictive models are available it would
be unwise for any country with resident popula-
tions of Culicoides insects, regardless of current
status for Orbivirus infection, to assume that one
or more of these viruses could not emerge at
some time in the future. However, any such
incursion can now be rapidly identified through
appropriate surveillance utilizing sensitive and
specific molecular diagnostic assays.
REFERENCES
[1] Adeyefa C.A., Hamblin C., Continuing preva-
lence of African horse sickness in Nigeria, Rev. Elev.
Med. Vet. Pays Trop. (1995) 48:31–33.
[2] Alexander R.A., The 1944 epizootic of horsesick-
ness in the Middle East, Onderstepoort J. Vet. Sci.
Anim. Ind. (1948) 23:77–92.
[3] Allison A.B., Goekjian G.H., Potgieter C., Wilson
W.C., Johnson D.J., Mertens P.P., Stallknecht D.E.,
Detection of a novel reassortant epizootic hemorrhagic
disease virus in the USA containing RNA segments
derived from both exotic (EHDV-6) and endemic
(EHDV-2) serotypes, J. Gen. Virol. (2009) 91:430–439.
[4] Anderson E.C., Mellor P., Hamblin C., African
horse sickness in Saudi Arabia, Vet. Rec. (1989)
125:489.
[5] Anonymous, OIE concern about climate change,
Vet. Rec. (2009) 164:735.
[6] Anonymous, Bluetongue, Terrestrial Animal
Health Code, Office International des Epizooties,
Paris, 2009.
[7] Anonymous, African horse sickness, Terestrial
Animal Health Code, Office International des Epizoo-
ties, Paris, 2009.
[8] Attoui H., Mendez-lopez M.R., Rao S., Hurtado-
Alendes A., Lizaraso-Caparo F., Jaafar F.M., et al.,
Peruvian horse sickness virus and Yunnan Orbivirus,
isolated from vertebrates and mosquitoes in Peru and
Australia, Virology (2009) 394:298–310.
[9] Balasuriya U.B.R., Nadler S.A., Wilson W.C.,
Pritchard L.I., Smythe A.B., Savini G., et al., The NS3
proteins of global strains of bluetongue virus evolve
into regional topotypes through negative (purifying)
selection, Vet. Microbiol. (2008) 126:91–100.
[10] Barnard B.J.H., Antibodies against some viruses
of domestic animals in southern African wild animals,
Onderstepoort J. Vet. Res. (1997) 64:95–110.
[11] Beebe N.W., Cooper R.D., Mottram P., Sweeney
A.W., Australia’s dengue risk driven by human
adaptation to climate change, PLoS Negl. Trop. Dis.
(2009) 3:e429.
[12] Bevan L.E.W., The transmission of African
horsesickness to the dog by feeding, Vet. J. (1911)
67:402–408.
[13] Binepal V.S., Wariru B.N., Davies F.G., Soi R.,
Olubayo R., An attempt to define the host range for
African horse sickness virus (Orbivirus, Reoviridae) in
East Africa, by a serological survey in some Equidae,
Camelidae, Loxodontidae and Carnivore, Vet. Micro-
biol. (1992) 31:19–23.
[14] Blackburn N.K., Swanepoel R., African horse
sickness in Zimbabwe: 1972 to 1981, Trop. Anim.
Health Prod. (1988) 20:169–176.
[15] Bonneau K.R., Zhang N., Zhu J., Zhang F., Li Z.,
Zhang K., et al., Sequence comparison of the L2 and
S10 genes of bluetongue viruses from the United States
and the People’s Republic of China, Virus Res. (1999)
61:153–160.
[16] Bonneau K.R., Mullens B.A., MacLachlan N.J.,
Occurrence of genetic drift and founder effect during
quasispecies evolution of the VP2 and NS3/NS3A
genes of bluetongue virus upon passage between
sheep, cattle, and Culicoides sonorensis, J. Virol.
(2001) 75:8298–8305.
[17] Bonneau K.R., MacLachlan N.J., Genetic diver-
sification of field strains of bluetongue virus, Vet. Ital.
(2004) 40:446–447.
[18] Borkent A., Grogan W.L., Catalog of the New
World biting midges north of Mexico (Diptera:
Ceratopogonidae), Zootaxa (2009) 2273:1–48.
[19] Burrage T.G., Laegreid W.W., African horse-
sickness: pathogenesis and immunity, Comp. Immu-
nol. Microbiol. Infect. Dis. (1994) 17:275–285.
[20] Coetzer J.A.W., Guthrie A.J., African horse
sickness, in: Coetzer J.A.W., Tustin R.C. (Eds.),
Infectious diseases of livestock, 2nd ed., Oxford
University Press Southern Africa, Cape Town, 2004,
pp. 1231–1246.
[21] Darpel K.E., Batten C.A., Veronesi E., Shaw
A.E., Anthony S., Bachanek-Bankowska K., et al.,
Clinical signs and pathology shown by British sheep
and cattle infected with bluetongue virus serotype 8
derived from the 2006 outbreak in northern Europe,
Vet. Rec. (2007) 161:253–261.
[22] Davies F.G., Oteino S., Elephants and zebras as
possible reservoir hosts for African horse sickness
virus, Vet. Rec. (1977) 100:291–292.
[23] Davies F.G., Soi R.K., Binepal V.S., African
horse sickness viruses isolated in Kenya, Vet. Rec.
(1993) 132:440.
[24] De Clercq K., De Leeuw I., Verheyden B.,
Vandemeulebroucke E., Vanbinst T., Herr C., et al.,
Re-emerging Orbivirus diseases Vet. Res. (2010) 41:35
(page number not for citation purpose) Page 9 of 12
Transplacental infection and apparently immunotoler-
ance induced by a wild-type bluetongue virus serotype
8 natural infection, Transbound. Emerg. Dis. (2008)
55:352–359.
[25] De Clercq K., Mertens P.P., De Leeuw I., Oura
C.A., Houdart P., Potgieter A.C., et al., Emergence of
bluetongue serotypes in Europe, Part 2: the occurrence
of a BTV-11 strain in Belgium, Transbound. Emerg.
Dis. (2009) 56:355–361.
[26] Dufour B., Moutou F., Hattenberger A.M.,
Rodhain F., Global change: impact, management risk
approach and health measures – the case of Europe,
Rev. Sci. Tech. (2008) 27:529–550.
[27] Elbers A.R., Backx A., Meroc E., Gerbier G.,
Staubach C., Hendrickx G., et al., Field observations
during the bluetongue serotype 8 epidemic in 2006. I.
Detection of first outbreaks and clinical signs in sheep
and cattle in Belgium, France and the Netherlands,
Prev. Vet. Med. (2008) 87:21–30.
[28] Erasmus B.J., Young E., Pieterse L.M., Boshoff
S.T., The susceptibility of zebra and elephants to
African horsesickness virus, in: Bryans J.T., Gerber H.
(Eds.), Equine infectious diseases IV, Veterinary
Publications Inc., Princeton, New Jersey, 1978,
pp. 409–413.
[29] Gale P., Brouwer A., Ramnial V., Kelly L.,
Kosmider R., Fooks A.R., Snary E.L., Assessing the
impact of climate change on vector-borne viruses in
the EU through the elicitation of expert opinion,
Epidemiol. Infect. (2009) 7:1–12.
[30] George J.E., The effects of global change on the
threat of exotic arthropods and arthropod-borne
pathogens to livestock in the United States, Anim.
Biodiv. Emerg. Dis. (2008) 1149:249–254.
[31] Gibbs E.P., Greiner E.C., The epidemiology of
bluetongue, Comp. Immunol. Microbiol. Infect. Dis.
(1994) 17:207–220.
[32] Gloster J., Burgin L., Witham C., Athanassiadou
M.,Mellor P.S., Bluetongue in the United Kingdom and
northern Europe in 2007 and key issues for 2008, Vet.
Rec. (2008) 162:298–302.
[33] Gould A.R., Hyatt A.D., The Orbivirus genus.
Diversity, structure, replication and phylogenetic rela-
tionships, Comp. Immunol. Microbiol. Infect. Dis.
(1994) 17:163–188.
[34] Gould E.A., Higgs S., Buckley A., Gritsun T.S.,
Potential Arbovirus emergence and implications for
the United Kingdom, Emerg. Infect. Dis. (2006)
12:549–555.
[35] Gould E.A., Higgs S., Impact of climate change
and other factors on emerging Arbovirus diseases,
Trans. R. Soc. Trop. Med. Hyg. (2009) 103:109–121.
[36] Guthrie A.J., African horse sickness, in: Sellon
D.C., Long M.T. (Eds.), Equine infectious diseases,
Saunders Elsevier, St. Louis, 2007, pp. 164–171.
[37] Guthrie A.J., Quan M., African horse sickness,
Equine Vet. Edu. (2009) Manual 8:120–128.
[38] Guthrie A.J., Pardini A.D., Howell P.G., Equine
encephalosis, Equine Vet. Edu. (2009) Manual 8:
145–150.
[39] Haig D.A., McIntosh B.M., Cumming R.B.,
Hempstead J.F.D., An outbreak of horsesickness,
complicated by distemper in a pack of foxhounds,
J. S. Afr. Vet. Med. Assoc. (1956) 27:245–249.
[40] Hazrati A., Identification and typing of horse-
sickness virus strains isolated in the recent epizootic of
the disease in Morocco, Tunisia and Algeria, Arch.
Inst. Razi (1967) 19:131–143.
[41] Henning M.W., African horsesickness, per-
desiekte, pestis equorum, Animal diseases of South
Africa, 3rd ed., Central News Agency Ltd., Pretoria,
1956, pp. 785–808.
[42] Hoffmann B., Beer M., Reid S.M., Mertens P.,
Oura C.A., Van Rijn P.A., et al., A review of RT-PCR
technologies used in veterinary virology and disease
control: sensitive and specific diagnosis of five
livestock diseases notifiable to the World Organisation
for Animal Health, Vet. Microbiol. (2009) 139:1–23.
[43] Hofmann M.A., Renzullo S., Mader M.,
Chaignat V., Worwa G., Thuer B., Genetic character-
ization of Toggenburg Orbivirus, a new bluetongue
virus, from goats, Switzerland, Emerg. Infect. Dis.
(2008) 14:1855–1861.
[44] Howell P.G., The 1960 epizootic of African
horsesickness in the Middle East and S.W. Asia, J. S.
Afr. Vet. Med. Assoc. (1960) 31:329–334.
[45] Howell P.G., The isolation and identification of
further antigenic types of African horsesickness virus,
Onderstepoort J. Vet. Res. (1962) 29:139–149.
[46] Howell P.G., Emerging diseases of animals. II.
African horsesickness, FAO Agric. Stud. (1963)
61:71–108.
[47] Howell P.G., Groenewald D., Visage C.W.,
Bosman A.M., Coetzer J.A.W., Guthrie A.J., The
classification of seven serotypes of equine encephalo-
sis virus and the prevalence of homologous antibody
in horses in South Africa, Onderstepoort J. Vet. Res.
(2002) 69:79–93.
[48] Howell P.G., Guthrie A.J., Coetzer J.A.W.,
Equine encephalosis, in: Coetzer J.A.W., Tustin R.C.
(Eds.), Infectious diseases of livestock, 2nd ed.,
Oxford University Press Southern Africa, Cape Town,
2004, pp. 1247–1251.
[49] Howell P.G., Nurton J.P., Nel D., Lourens C.W.,
Guthrie A.J., Prevalence of serotype specific antibody
Vet. Res. (2010) 41:35 N.J. MacLachlan, A.J. Guthrie
Page 10 of 12 (page number not for citation purpose)
to equine encephalosis virus in Thoroughbred year-
lings in South Africa (1999–2004), Onderstepoort
J. Vet. Res. (2008) 75:153–161.
[50] Jauniaux T.P., De Clercq K.E., Cassart D.E.,
Kennedy S., Vandenbussche F.E., Vandemeulebroucke
E.L., et al., Bluetongue in Eurasian lynx, Emerg.
Infect. Dis. (2008) 14:1496–1498.
[51] Kitano Y., Ibaraki disease in cattle, in: Coetzer
J.A.W., Tustin R.C. (Eds.), Infectious diseases of
livestock, 2nd ed., Oxford University Press Southern
Africa, Cape Town, 2004, pp. 1221–1226.
[52] Lubroth J., African horsesickness and the epizo-
otic in Spain 1987, Equine Pract. (1988) 10:26–33.
[53] MacDonald N.E., West Nile virus in the context
of climate change, Can. J. Infect. Dis. Med. Microbiol.
(2008) 19:217–218.
[54] MacLachlan N.J., Osburn B.I., Epizootic hem-
orrhagic disease of deer, in: Coetzer J.A.W., Tustin
R.C. (Eds.), Infectious diseases of livestock, 2nd ed.,
Oxford University Press Southern Africa, Cape Town,
2004, pp. 1227–1230.
[55] MacLachlan N.J., Osburn B.I., Impact of blue-
tongue virus infection on the international movement
and trade of ruminants, J. Am. Vet. Med. Assoc.
(2006) 228:1346–1349.
[56] MacLachlan N.J., Dubovi E., Veterinary and
zoonotic virology, 4th ed., Elsevier, 2010.
[57] MacLachlan N.J., Drew C.P., Darpel K.E.,
Worwa G., The pathology and pathogenesis of blue-
tongue, J. Comp. Pathol. (2009) 141:1–16.
[58] MacLachlan N.J., Global implications of the
recent emergence of bluetongue in Europe, Vet. Clin.
North Am. (2010) 26:163–171.
[59] Mauroy A., Guyot H., De Clercq K., Cassart D.E.,
Thiry E., Saegerman C., Bluetongue in captive yaks,
Emerg. Infect. Dis. (2008) 14:675–676.
[60] McIntosh B.M., Horsesickness antibodies in the
sera of dogs in enzootic areas, J. S. Afr. Vet. Med.
Assoc. (1955) 26:269–272.
[61] McIntosh B.M., Immunological types of horse-
sickness virus and their significance in immunization,
Onderstepoort J. Vet. Res. (1958) 27:465–539.
[62] Meiswinkel R., Baylis M., Labuschagne K.,
Stabling and the protection of horses from Culicoides
bolitinos (Diptera: Ceratopogonidae), a recently iden-
tified vector of African horse sickness, Bull. Entomol.
Res. (2000) 90:509–515.
[63] Mertens P.P., Diprose J., Maan S., Singh K.P.,
Attoui H., Samuel A., Bluetongue virus replication,
molecular and structural biology, Vet. Ital. (2004)
40:426–437.
[64] Mildenberg Z., Westcott D., Bellaiche M.,
Dastjerdi A., Steinbach F., Drew T., Equine enceph-
alosis virus in Israel, Transbound. Emerg. Dis. (2009)
56:291.
[65] Petersen L.R., Hayes E.B., West Nile virus in the
Americas, Med. Clin. North Am. (2008) 92:1307–
1322.
[66] Pialoux G., Gauzere B.A., Jaureguiberry S.,
Strobel M., Chikungunya, an epidemic arbovirosis,
Lancet Infect. Dis. (2007) 7:319–327.
[67] Piercy S.E., Some observations on African
horse-sickness including an account of an outbreak
among dogs, East Afr. Agric. J. (1951) 17:62–64.
[68] Pinto J., Bonacic C., Hamilton-West C., Romero
J., Lubroth J., Climate change and animal diseases in
South America, Rev. Sci. Tech. (2008) 27:599–613.
[69] PurseB.V.,Mellor P.S., RogersD.J., SamuelA.R.,
Mertens P.P., Baylis M., Climate change and the
recent emergence of bluetongue in Europe, Nat. Rev.
Microbiol. (2005) 3:171–181.
[70] Purse B.V., Brown H.E., Harrup L., Mertens
P.P.C., Rogers D.J., Invasion of bluetongue and other
Orbivirus infections into Europe: the role of biological
and climatic processes, Rev. Sci. Tech. (2008) 27:
427–442.
[71] Quan M., van Vuuren M., Howell P.G.,
Groenewald D., Guthrie A.J., Molecular epidemiology
of the African horse sickness virus S10 gene, J. Gen.
Virol. (2008) 89:1159–1168.
[72] Reid N.R., African horse sickness, Br. Vet. J.
(1961) 118:137–142.
[73] Rodriguez M., Hooghuis H., Castano M.,
African horse sickness in Spain, Vet. Microbiol.
(1992) 33:129–142.
[74] Rogers D.J., Randolph S.E., Climate change and
vector-borne diseases, Adv. Parasitol. (2006) 62:
345–381.
[75] Russell R.C., Currie B.J., Lindsay M.D.,
Mackenzie J.S., Ritchie S.A., Whelan P.I., Dengue
and climate change in Australia: predictions for the
future should incorporate knowledge from the past,
Med. J. Aust. (2009) 190:265–268.
[76] Sailleau C., Seignot J., Davoust B., Cardinale E.,
Fall B., Hamblin C., Zientara S., African horse
sickness in Senegal: serotype identification and nucle-
otide sequence determination of segment S10 by
RT-PCR, Vet. Rec. (2000) 146:107–108.
[77] Schwartz-Cornil I., Mertens P.P., Contreras V.,
Hemati B., Pascale F., Bre´ard E., et al., Bluetongue
virus: virology, pathogenesis and immunity, Vet. Res.
(2008) 39:46.
Re-emerging Orbivirus diseases Vet. Res. (2010) 41:35
(page number not for citation purpose) Page 11 of 12
[78] Sellers R.F., Pedgley D.E., Tucker M.R., Possi-
ble spread of African horse sickness on the wind, J.
Hyg. (1977) 79:279–298.
[79] Tabachnick W.J., Culicoides and the global
epidemiology of bluetongue virus infection, Vet. Ital.
(2004) 40:145–150.
[80] Theiler A., Transmission of horse sickness into
dogs, Rep. Govern. Vet. Bacteriol. (1906) 160–162.
[81] Theiler A., Notes on a fever in horses simulating
horse-sickness, Transvaal. Agric. J. (1910) 8:581–586.
[82] Theiler A., African horse sickness (pestis equo-
rum), Sci. Bull. (1921) 19:1–29.
[83] Thom H.B., Journal of Jan van Riebeeck, A.A.
Balkema, Cape Town/Amsterdam, 1952.
[84] Verwoerd D.W., Erasmus B.J., Bluetongue, in:
Coetzer J.A.W., Tustin R.C. (Eds.), Infectious diseases
of livestock, 2nd ed., Oxford University Press South-
ern Africa, Cape Town, 2004, pp. 1201–1220.
[85] Weaver S.C., Reisen W.K., Present and future
arboviral threats, Antiviral Res. (2009) 85:328–345.
[86] Wilson A.J., Mellor P.S., Bluetongue in Europe:
past, present and future, Philos. Trans. R. Soc. Lond. B
Biol. Sci. (2009) 364:2669–2681.
[87] Wouda W., Roumen M.P., Peperkamp N.H., Vos
J.H., van Garderen E., Muskens J., Hydranencephaly
in calves following the bluetongue serotype 8
epidemic in the Netherlands, Vet. Rec. (2008) 162:
422–423.
[88] Wouda W., Peperkamp N.H., Roumen M.P.,
Muskens J., van Rijn A., Vellema P., Epizootic
congenital hydranencephaly and abortion in cattle
due to bluetongue virus serotype 8 in the Netherlands,
Tijdschr. Diergeneeskd. (2009) 134:422–427.
[89] Yadin H., Brenner J., Brumbrov V., Oved Z.,
Stram Y., Klement E., et al., Epizootic haemorrhagic
disease virus type 7 infection in cattle in Israel, Vet.
Rec. (2008) 162:53–56.
[90] Zeleke A., Sori T., Powel K., Gebre-Ab F.,
Endebu B., Isolation and identification of circulating
serotypes of African horse sickness virus in Ethiopia,
Intern. J. Appl. Res. Vet. Med. (2005) 3:40–43.
[91] Zell R., Krumbholz A., Wutzler P., Impact
of global warming on viral diseases: what is the
evidence?, Curr. Opin. Biotechnol. (2008) 19:652–660.
[92] Zientara S., Sailleau C., Plateau E., Moulay S.,
Mertens P.P., Cruciere C., Molecular epidemiology of
African horse sickness virus based on analyses and
comparisons of genome segments 7 and 10, Arch.
Virol. Suppl. (1998) 14:221–234.
Vet. Res. (2010) 41:35 N.J. MacLachlan, A.J. Guthrie
Page 12 of 12 (page number not for citation purpose)
